Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8+ T cells

Journal of Immunology

Volumn 168, Issue 11, 2002, Pages 5403-5408

  Basta, Sameh ^a   Chen, Weisan ^a   Bennink, Jack R ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN US11; PROTEIN US2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL LYSATE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOCOMPATIBILITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; T LYMPHOCYTE; VACCINIA VIRUS;

EID: 0036604250     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.11.5403     Document Type: Article

References (39)

1. + T cell effector mechanisms in resistance to infection
2. Lymphohemopoietic origin of the immunogenic, virus-antigen-presenting cells triggering anti-viral T-cell responses
3. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
4. + T cells: Cross-priming in infectious diseases
5. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation
6. Cutting edge: Recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells
7. Viral subversion of the immune system
8. + T cells in major histocompatibility complex class II-deficient mice
9. + T cell repertoire and antilymphocytic choriomeningitis virus cytolytic responses
10. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules
11. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques
12. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses
13. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
14. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11
15. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains
16. + T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses
17. + T cells
18. Antiviral immune responses of mice lacking MHC class II molecules or its associated invariant chain
19. Quantitating presentation of MHC class I-restricted antigens
20. + cytotoxic T lymphocytes
21. Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus
22. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum
23. + T cell response
24. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons: An intricate balance
25. Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis
26. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens
27. Impaired intracellular transport of class I MHC antigens as a possible means for adenovirus to evade immune surveillance
28. Cutting edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression
29. + T cells by infected dendritic cells in vivo
30. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response
31. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
32. T cell help
33. + T cells at the levels of T cell repertoire and presentation of viral antigens
34. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway
35. + T cell responses
36. Similar as well as distinct MHC class 1-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen
37. + T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing
38. + T cells in vivo
39. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis